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Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli strain C999 was
isolated of a Spanish patient with urinary tract infection. Previous genotyping indicated
that this strain presented a multidrug-resistance phenotype and carried beta-lactamase
genes encoding CTX-M-15, TEM-1, and OXA-1 enzymes. The whole-cell proteome,
and the membrane, cytoplasmic, periplasmic and extracellular sub-proteomes of C999
were obtained in this work by two-dimensional gel electrophoresis (2DE) followed by
fingerprint sequencing through matrix-assisted laser desorption/ionization time-of-flight
mass spectrometry (MALDI-TOF/MS). A total of 602 proteins were identified in the
different cell fractions, several of which are related to stress response systems, cellular
responses, and antibiotic and drug responses, consistent with the multidrug-resistance
phenotype. In parallel, whole genome sequencing (WGS) and RNA sequencing (RNA-
Seq) was done to identify and quantify the genes present and expressing. The in silico
prediction following WGS confirmed our strain as being serotype O25:H4 and sequence
type ST131. The presence of proteins related to antibiotic resistance and virulence
in an O25:H4-ST131 E. coli clone are serious indicators of the continued threat of
antibiotic resistance spread amongst healthcare institutions. On a positive note, a
multiomics approach can facilitate surveillance and more detailed characterization of
virulent bacterial clones from hospital environments.
Keywords: bacteria, antimicrobial resistance, public health, genomics, transcriptomics, proteomics
Abbreviations: 2DE, two-dimensional gel electrophoresis; ACN, acetonitrile; DTT, dithiothreitol; ESBL, extended-spectrum
β-lactamase producing; FPKM, fragments per kilo base per million mapped reads; IPG, ImmobilineTM pH Gradient;
MALDI-TOF/MS, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; PAGE, polyacrylamide gel;
RNA-Seq, RNA sequencing; SDS, sodium dodecyl sulfate; TCA, trichloroacetic acid; WGS, whole genome sequencing.
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INTRODUCTION
Rates of Gram-negative healthcare-associated infections have
been increasing since 1998, mostly caused by antimicrobial
resistant Enterobacteriaceae. A strikethrough recent worldwide
survey revealed the prevalence of extended-spectrum beta-
lactamase (ESBL)-producing Enterobacteriaceae in 14% of
healthy individuals, a rate predicted to increase by 5.38%
year on year overall (Karanika et al., 2016; Bassetti et al.,
2017). Patients hospitalized in intensive care units and in long-
term care facilities, or those who are immunocompromised
have a higher risk of acquiring multidrug-resistant Gram-
negative infections (Kunz and Brook, 2010). ESBLs are enzymes
encoded by plasmid-borne genes, typically from the TEM,
SHV, CTX-M families, that mediate resistance to oxyimino-
beta-lactam antibiotics, third-generation cephalosporins and
aztreonam (Rice, 2009; Drawz and Bonomo, 2010). For years,
Escherichia coli producing the CTX-M-15 variant have been
frequently implicated in human infection (Ewers et al., 2010).
It has also been noted that the blaCTX−M−15 gene is located
49 bp downstream of insertion sequence ISEcp1, a well-known
highly efficient mobile element playing a major role in the
expression and spread of CTX-M beta-lactamases, the most
common in Europe (Peirano and Pitout, 2010; Guiral et al.,
2011). Throughout the years, the ciprofloxacin-resistant CTX-
M-15-producing O25:H4-ST131 E. coli clonal group is known
to have caused major outbreaks worldwide (Nicolas-Chanoine
et al., 2008; Ewers et al., 2010; Johnson et al., 2017). Classed
as a member of the virulent phylogenetic group B2 and having
the multidrug-resistant profile of the sequence type (ST) 131
clonal group, the O25:H4-ST131 clone represents a major public
health problem as it makes it more complicated to select
an appropriate therapy to administer, with a higher risk of
increased costs and use of “last resort” antibiotics (Vimont
et al., 2012). ST131 is therefore seen as being at the leading
edge of a deeply concerning set of increasingly challenging
infection agents (Vimont et al., 2012; Johnson et al., 2017).
In the present work, we studied an ESBL-producing E. coli
strain of human clinical origin, designated C999, that was
previously studied and characterized by Ruiz et al. (2012).
C999 was resistant to fluoroquinolones and third generation
cephalosporins because of CTX-M-15 ESBL and belonged to
phylogenetic group B2 and ST131. According to the genomic
profile of E. coli C999 we assumed that this strain is related to the
hazardous intercontinental O25:H4-ST131 clone. In our research,
we took a multiomics approach to more deeply characterize
this significant clinical strain. Whole-genome sequencing (WGS)
and RNA sequencing (RNA-Seq) analysis were conducted to
confirm if the E. coli C999 strain belongs to the O25:H4
serotype and identify/quantify the genes expressed. In parallel,
proteomic maps of C999 were produced by two-dimensional
gel electrophoresis (2DE) of whole-cell and fractionated extracts
followed by matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOF/MS) of peptides
(Vlaanderen et al., 2010). This allowed us to monitor how
resistance mechanisms affect the proteomes of the membrane and
cytoplasmic compartments.
MATERIALS AND METHODS
Whole-Genome Sequencing
Total DNA was extracted from E. coli C999 using a silica-based
automatic DNA extractor EasyMag (BioMérieux Inc., Durham,
United States). A sequencing library was generated using the
Nextera XT DNA library preparation kit (Illumina Inc., San
Diego, CA, United States) and sequenced on a MiSeq (Illumina
Inc., San Diego, CA, United States) using paired-end reads
(2 × 150 bp), according to the manufacturer’s instructions.
FastQC1 and Trimmomatic2 software tools were used for read
quality analysis and improvement, respectively (D’Antonio et al.,
2015; Williams et al., 2016). Genome assembly and annotation
were done using SPAdes3 and RAST annotation4, respectively.
Finally, putative antimicrobial resistance genes were predicted
using Comprehensive Antibiotic Resistance Database (CARD5)
(Jia et al., 2017). WGS raw reads were submitted to the European
Nucleotide Archive under the accession numbers ERR3013427.
RNA Library Preparation and Sequencing
Total RNA was extracted using the RNeasy Mini Kit (Qiagen,
Venlo, Netherlands) with RNase-free DNase treatment on the
column (Qiagen), followed by bacterial rRNA depletion using
a Ribo-Zero rRNA Removal Kit (Illumina Inc., San Diego, CA,
United States). The 2100 Bioanalyzer (Agilent, Santa Clara, CA,
United States) was used to evaluate the concentration and quality
of RNA samples pre- and post-depletion. For RNA-Seq analysis,
a library was prepared with rRNA-depleted samples using the
TruSeq Stranded mRNA LT Sample Prep Kit (Illumina). RNA
was sequenced on a MiSeq using paired-end (2 × 75 bp) reads
(Illumina), according to the manufacturer’s instructions.
Transcriptomic Data Analysis
The quality of raw RNA-Seq data was evaluated using FastQC
analysis. The sequence reads were then mapped against the
obtained whole-genome sequence of strain C999 using the
Bowtie2 algorithm6 (Version 2.1.0). The expression level of each
transcript was calculated using the Cuﬄinks software7 (Version
2.1.1) by normalizing data as fragments per kilobase of coding
sequence per million mapped reads (FPKM).
Whole-Cell Protein Extraction
Cells were grown in brain heart infusion agar for 24 h and
afterward cultivated in brain heart infusion broth (15 ml) for
4 h (Goncalves et al., 2014). Exponentially growing cells were
then harvested by centrifugation (3 min, 10,000 g, 4◦C) and
resuspended in 4 ml of phosphate-buffered saline at room
temperature, centrifuged again, then resuspended in 0.2 ml of
10% (w/v) sodium dodecyl sulfate (SDS), 12% (w/v) Tris (Celis
1http://www.bioinformatics.babraham.ac.uk/projects/fastqc/
2http://www.usadellab.org/cms/?page=trimmomatic
3http://bioinf.spbau.ru/spades
4http://rast.nmpdr.org/
5https://card.mcmaster.ca/
6http://bowtie-bio.sourceforge.net/bowtie2/index.shtml
7http://cuﬄinks.cbcb.umd.edu/
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and Gromov, 1999). Cells were disrupted by sonication with
an ultrasonic homogenizer (Vibra-CellTM VCX130, Sonics &
Materials Inc., Newtown, United States) in three 10 s bursts at
40% of full power, then cell debris was removed by centrifugation
(14,000 g, 30 min, 4◦C). The clear supernatant was collected then
mixed with an equal volume of cold 20% (w/v) trichloroacetic
acid (TCA; Merck, Darmstadt, Germany) in acetone (Sigma-
Aldrich, St. Louis, MO, United States) and was kept at−20◦C for
1 h. The precipitate was collected by centrifugation at 13,000 g for
30 min at 4◦C. The precipitated protein was washed thrice with
acetone to remove traces of TCA. Residual acetone was removed
by air-drying. Protein pellets were solubilized in thiourea/urea
lysis buffer. The resulting solutions were stored at −80◦C for
further analysis.
Extracellular Protein Extraction
Extracellular proteins were prepared as previously described with
some modifications (Nandakumar et al., 2006; Xia et al., 2008;
Goncalves et al., 2014). Cells were removed from brain heart
infusion broth culture by centrifugation at 5500 g for 10 min
at 4◦C. The clear supernatant was collected, passed through a
0.22 µm filter, mixed with an equal volume of cold 20% (w/v)
TCA in acetone, and kept at −20◦C for 1 h. The precipitate
formed after centrifugation at 13,000 g for 30 min at 4◦C was
washed thrice with acetone to remove traces of TCA, and residual
acetone was removed by air-drying. Dried protein pellets were
solubilized in thiourea/urea lysis buffer [2 M thiourea, 7 M
urea, 4% (w/v) CHAPS, 1% (w/v) dithiothreitol (DTT), 2% (v/v)
carrier ampholytes (pH 3–10) and 10 mM Pefabloc R© proteinase
inhibitor], then stored at−80◦C for further analysis.
Periplasmic and Cytoplasmic Protein
Extraction
To extract periplasmic and cytoplasmic protein from bacterial
cultures, the Epicentre PeriprepsTM Periplasting kit (Epicentre,
WI, United States) was used with a few modifications to the kit
protocol. The bacterial cell culture was centrifuged at 5500 g
for 10 min and the supernatant discarded. The pellet was
resuspended by pipetting in 2 ml of PeriPrepsTM Periplasting
buffer (200 mM Tris-HCl pH 7.5, 20% sucrose, 1 mM EDTA,
and 30 U/µl Ready-Lyse lysozyme) for each gram of cell pellet.
The sample was incubated for 5 min at room temperature.
Osmotic shock was induced by rapidly adding 3 ml of ice-cold
water for each gram of original cell pellet, mixing the sample
by inverting the centrifuge tubes. The sample was kept on ice
for 10 min then centrifuged at 12,000 g for 2 min to separate
the pellet (spheroplasts and intact cells) from the supernatant,
the periplasmic fraction. Spheroplasts in the pellet were lysed
by adding a detergent lysis buffer (10 mM KCl, 1 mM EDTA,
and 0.1% deoxycholate) and the pellet was resuspended in 5 ml
of PeriPreps lysis buffer for each gram of original cell pellet
and incubated for 5 min at room temperature. The sample was
sonicated with 2 s bursts at 40% of full power for a total of
1 min. Cell debris was removed by centrifugation at 12,000 g for
15 min at 4◦C. The supernatant was removed and centrifuged as
before. The supernatant recovered was the cytoplasmic fraction.
Equal volumes of cold 20% (w/v) TCA in acetone were mixed
with both periplasmic and cytoplasmic fractions that were then
kept at −20◦C Tris-HCl pH 7.5, 50 for 1 h. The precipitates
collected after centrifugation at 13,000 g for 30 min at 4◦C
were washed thrice with acetone to remove traces of TCA.
Residual acetone was removed by air-drying. Protein pellets were
solubilized in thiourea/urea lysis buffer and stored at −80◦C for
further analysis.
Membrane Protein Extraction
Membrane proteins were isolated by a previously described
method with some modifications (Taddei et al., 2011). Bacterial
cells were recovered from liquid culture by centrifugation at
10,000 g for 3 min at 4◦C and the pellet was resuspended
in phosphate-buffered saline pH 7.4 (Gorg et al., 2004).
After a second similar centrifugation step, the pellet was
resuspended in 25 ml of 10 mM Tris buffer pH 8.8 with
1 mM phenylmethylsulfonylfluoride (Sigma-Aldrich). Cells were
disrupted with 3 cycles of 20 s bursts of sonication at 40% of
full power and the cell debris was removed by centrifugation at
12,000 g for 2 min at room temperature. The supernatant was
centrifuged at 49,500 g for 60 min at 4◦C (in a 3–30KS centrifuge
with rotor no.12158, Sigma GmbH, Osterode am Harz, Germany)
and the pellet was treated with 1.67% N-lauroylsarcosine sodium
salt (Sigma-Aldrich) for 20 min at room temperature. The
membrane proteins were recovered by centrifugation at 23,000 g
for 90 min at 4◦C and the pellet was solubilized in thiourea/urea
lysis buffer. Samples were stored at−80◦C for further analysis.
Protein Quantification
Protein concentration was determined using the 2-D Quant kit
(GE Healthcare, Buckinghamshire, United Kingdom) following
the manufacturer’s instructions. In this procedure proteins are
quantitatively precipitated leaving other substances in solution.
The precipitated proteins are then resuspended in a copper-
containing solution with the unbound copper being measured
with a colorimetric agent. Color density (absorbance at 480 nm) is
thus inversely related to the protein concentration and accurately
reflects the protein concentration of the sample.
One-Dimensional and Two-Dimensional
Electrophoresis
One-dimensional electrophoresis was done with SDS-
polyacrylamide (SDS-PAGE) gels (T = 12.52%, C = 0.97%)
in a HoeferTM SE 600 Ruby R© unit (GE Healthcare, Chicago,
United States) as described by Laemmli (1970) with some
modifications (Igrejas, 2000). Whole-cell protein extract (15 µg)
was resuspended in an equal volume of buffer containing 0.5
M Tris HCl pH 8.0, glycerol, SDS and bromophenol blue. After
protein separation at 30 mA, gels were stained for 24 h in
Coomassie Brilliant Blue R-250 and washed in water overnight.
Gels were then fixed in 6% TCA for 4 h and in 5% glycerol for
2 h (Gorg et al., 2009). Two-dimensional electrophoresis (2DE)
was performed according to the principles of O’Farrell but with
ImmobilineTM pH Gradient (IPG) technology (O’Farrell, 1975;
Gorg et al., 2009). For the first dimension of isoelectric focusing,
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precast 13 cm IPG strips with linear gradients of pH 3–10 (GE
Healthcare) were passively rehydrated for 12–16 h in a reswelling
tray with 250 µl of rehydration buffer (8M urea, 1% CHAPS,
0.4% DTT, and 0.5% carrier ampholyte IPG buffer pH 3–10) at
room temperature. IPG strips were covered with Drystrip Cover
Fluid (Plus One, GE Healthcare). Lysis buffer [9.5 M urea, 1%
(w/v) DTT, 2% (w/v) CHAPS, 2% (v/v) carrier ampholytes (pH
3–10), and 10 mM Pefabloc R© proteinase inhibitor] was added to
E. coli protein extracts to achieve a concentration of 1 µg/µl of
protein. Samples containing a total of 100 µg of protein were
cup-loaded onto the rehydrated 13-cm IPG strips (Gorg et al.,
2009). To optimize running conditions, isoelectric focusing
replicate runs were performed according to Gorg et al. (2009)
and the GE Healthcare protocol for 13 cm IPG strips pH 3–10
on an EttanTMIPGPhor IITM (GE Healthcare). The optimized
13 h run was as follows: sample proteins were focused at 500 V
for 1 h, followed by a gradient up to 1000 V for 8 h, then a
gradient up to 8000 V for 3 h, finally remaining at 8000 V for
1 h. Focused IPG strips were then stored at −80◦C in plastic
bags. Before running the second dimension of electrophoresis,
strips were equilibrated twice for 15 min in equilibration buffer
[6M urea, 30% (w/v) glycerol, 2% (w/v) SDS in 0.05M Tris-HCl
buffer (pH 8.8) with bromophenol blue] with 1% DTT included
in the first equilibration and 4% iodoacetamide in the second
one. The equilibrated IPG strips were briefly rinsed with SDS
electrophoresis buffer, blotted to remove any excessive buffer,
and then loaded onto 12.52% polyacrylamide gels in a HoeferTM
SE 600 Ruby R© unit (GE Healthcare). The SDS-PAGE technique
previously reported by Laemmli (1970) was modified to increase
the resolution with the proper insertion of the IPG strips in
the stacking gel (Laemmli, 1970; Igrejas, 2000). SDS-PAGE was
run at 440 V for 3 h. Gels were fixed in 40% methanol, 10%
acetic acid for 1 h, then stained overnight in Coomassie Brilliant
Blue G-250 (Gorg et al., 2009). Coomassie-stained gels were
scanned on a flatbed scanner (UmaxPowerLook 1100, Freemont,
CA, United States) and the digitized images were analyzed
using Lab Scanner Image Master 5.0 software (GE Healthcare).
Protein molecular weights were estimated by comparison with
an internal calibration marker.
Protein Identification by MALDI-TOF/MS
For each extraction method, gels were analyzed and compared
with each other. Spots that were expressed in all gels were
manually excised from the gels and analyzed using MALDI-
TOF/MS. Gel pieces were rehydrated twice in 200 µl Milli-Q
water and washed twice with 25 mM ammonium bicarbonate,
50% acetonitrile (ACN), once with 50 µl ACN, then dried
in a SpeedVac (Thermo Fisher Scientific, Waltham, MA,
United States). To digest the proteins, 15 µl of trypsin solution
[0.02 µg/µl trypsin (Promega, Madison, WI, United States),
12.5 mM ammonium bicarbonate, 2% (v/v) can] was added to the
dried gel pieces, which were then kept on ice for 1 h before adding
30 µl of 12.5 mM ammonium bicarbonate and incubating them
overnight at 37◦C. Tryptic peptides were extracted by adding
20 µl of 5% formic acid, 50% ACN and then 25 µl of 50% ACN,
0.1% trifluoroacetic acid followed by threefold lyophilization in
a SpeedVac (Thermo Fisher Scientific). Tryptic peptides were
resuspended in 10 µl of 0.3% formic acid. Samples were mixed
(1:2, v/v) with 1 µl of a saturated matrix solution of 5 mg/ml
α-cyano-4-hydroxycinnamic acid in 0.1% (v/v) trifluoroacetic
acid, 50% (v/v) ACN, 8 mM ammonium phosphate). Aliquots
of samples (0.5 µl) were spotted onto the MALDI sample target
plate (384-spot ground-steel plate). Peptide mass spectra were
obtained from a MALDI-TOF/MS Ultraflex mass spectrometer
(Bruker Daltonics, Bremen, Germany) operating in positive
ion reflectron-mode. Spectra were acquired in the m/z range
of 600–3500 Da at a laser frequency of 50 Hz. For each spot
analyzed, a data-dependent acquisition method was created
to select the six most intense peaks, excluding those from the
matrix, trypsin autolysis, or acrylamide, for subsequent MS/MS
data acquisition. Mass spectra were internally calibrated with
self-digested trypsin peaks (MH+: 842.5, 2211.42 Da) allowing
a mass accuracy of better than 25 ppm. External calibration was
performed with the [M+H]+monoisotopic peaks of bradykinin
1–7 (m/z 757.3992), angiotensin II (m/z 1046.5418), angiotensin
I (m/z 1296.6848), substance P (m/z 1758.9326), ACTH clip 1–17
(m/z 2093.0862), ACTH18–39 (m/z 2465.1983), and
somatostatin 28 (m/z 3147.4710).
Bioinformatics Analysis for Proteomics
Spectra were processed and analyzed using the Global Protein
Server Workstation (Applied Biosystems), which uses internal
MASCOT software (v 2.1.04, Matrix Science, London,
United Kingdom) to search for peptide mass fingerprints
within MS/MS data. The Swiss-Prot non-redundant protein
sequence database (Release 10 of October 2014, 546790 entries)
and NCBI Reference Sequence Database (RefSeq release 68 of
November 2014, 46968574 protein entries) were used to search
E. coli protein sequences. The database search parameters were
as follows: carbamidomethylation and propionamide of cysteine
(+71 Da) and oxidation of methionine (+16 Da) as variable
modifications, allowance for up to two missed tryptic cleavages,
peptide mass tolerance of 50 ppm, and fragment ion mass
tolerance of 0.3 Da. Positive identifications were accepted above
95% of confidence level. Protein identifications were considered
as reliable when the MASCOT score was >70% calculated
as –10 × log P, where P is the probability that the observed
match is a random event. This is the lowest score indicated by
the program as being significant (P < 0.05) below which proteins
are likely to be incorrectly identified.
RESULTS AND DISCUSSION
E. coli C999 Strain Profile
Genomics and Transcriptomics
ESBL-producing E. coli strain C999, implicated in a urinary
infection of a Spanish patient was collected in 2007 and used
in this study, thus characterized in relation to the phenotype
and genotype of antimicrobial resistance and to molecular
typing (Ruiz et al., 2012). This strain was resistant to ampicillin,
amoxicillin/clavulanic acid, cefotaxime, ceftazidime, naladixic
acid, ciprofloxacin, tobramycin, kanamycin, streptomycin,
tetracycline, sulfamides and trimethoprim-sulfametoxazole, and
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carried the blaCTX−M−15, blaOXA−1, and blaTEM−1b β-lactamase
genes. Other resistance genes observed in strain C999 were
aac(6’)-Ib-cr (ciprofloxacin resistance), tet(A) (tetracycline
resistance) and sul1 (sulfametoxazole resistance). The gene
cassette array dfrA17 + aadA5 was observed in strain C999 and
mutations were also found in genes encoding GyrA (Ser83Leu +
Asp87Asn) and ParC proteins (Ser80Ile + Glu84Val) (Ruiz et al.,
2002). C999 was classified in the phylogenetic group B2, mostly
implicated in extraintestinal infections (Clermont et al., 2000),
and it belongs to sequence type ST131, as previously detected
(Ruiz et al., 2012). To better understand the nature of the C999
strain we produced a comprehensive survey of its genome,
transcriptome and proteome. WGS allowed comprehensive
characterization of the genetic makeup of the bacterial strain,
including the identification of antibiotic resistance genes,
consistent with the known pathological nature of this strain
previously determined by Ruiz and colleagues (Ruiz et al.,
2012). In fact, in silico prediction was applied to the WGS assay
using SerotypeFinder 2.0, thus confirming the O25:H4 serotype
which can lead us to acknowledge our strain as a member of
the O25:H4-ST131 E. coli clonal group (Joensen et al., 2015).
Supplementary Table S1 display all the identified genes related
to antibiotic resistance such as aac(6’)-Ib-cr, tet(A), sul1, aadA5
gene cassette and genes related to toxin-antitoxin addiction
systems of plasmids pemK, ccdA/ccdB, vagC/vagD, and sok, as
well as β-lactamase genes blaTEM−1, blaOXA−1, and blaCTX−M−15.
It is important to also highlight the presence of several stress
response and oxidoreductase genes. This perspective of the C999
transcriptome gives an overview of all its cellular mechanisms
(Supplementary Table S2).
Proteomics
The 2DE gels of the whole-cell proteome and four sub-proteomes
of E. coli strain C999 were compared (Figures 1, 2). From all
the gels, a total of 564 protein spots were collected for analysis
using MALDI-TOF/MS and identified by correlating the output
with bioinformatics databases8. A total of 602 different proteins
were identified from 471 different spots, which corresponds to
83.51% of the total spots collected (Supplementary Tables S5–
S9). The proteins identified were related to different functions
within bacterial cell metabolism, the most frequent being enzyme
activity, transport and molecule/protein biosynthesis, followed by
the stress response, the SOS response and antibiotic resistance
(Figures 3–5). Proteins related to glycolysis and molecule
biosynthesis were indeed well represented in all proteomes
(Figure 6). In fact, 282 different proteins were identified as
involved in biological processes of regular cell functioning and 42
proteins were found to be related to stress response mechanisms,
as has been previously described (Micevski and Dougan, 2013;
Delmar et al., 2014).
Comparison of RNA and Proteins
Expressed in E. coli C999
With the use of RNA-Seq the abundance of all transcripts
was quantified, thus allowing to compare the gene expression
8http://www.ncbi.nlm.nih.gov/
levels to the proteomic data (Supplementary Table S3; Han
et al., 2015; Salipante et al., 2015). Supplementary Table S4
summarizes the relevant genes identified with their lengths
and abundance in FPKMs, juxtaposed with the proteomic data
obtained and corresponding protein score. Taking an overview
of all the data obtained, it is interesting to see that among
the top-100 most highly expressed genes only 25 corresponded
to detected proteins, whereas only 80 detected proteins were
among the top-500 expressed genes. In fact, gene blaCTX−M−15
was identified with an expression level of 355 FPKM being
placed in the top-1000 although not being detected at the
proteome level. The lack of correlation between mRNA and
protein expression was already referred in previous studies,
where different possibilities were advanced to explain this matter
(Haider and Pal, 2013; Koussounadis et al., 2015; Liu et al.,
2016). Considering the most highly expressed genes which
did correlate well with the proteomic data in our survey,
we can highlight the antibiotic resistance-related gene blaTEM
and also elongation factor tufA, as well as stress response
genes dps, clpB, dnaK, and groEL (Supplementary Table S3).
According to the genomic and transcript sequences, various
expressed genes are related to multidrug resistance mechanisms.
One example is the eﬄux pump AcrA-AcrB-TolC located
in the intermembrane structure of Gram-negative bacteria,
which ejects antibiotics and other compounds from the cell,
thus playing an important part in the survival of pathogenic
microorganisms (Supplementary Table S2; Tikhonova and
Zgurskaya, 2004; Wang et al., 2009; Du et al., 2014). Adaptor
protein (AcrA) and outer membrane channel (TolC) transcripts
were both detected in RNA-Seq, and the AcrA homolog
AcrE, the transcriptional repressor AcrR, and the potential
AcrA-repressor AcrS were all expressed but at different levels
(Supplementary Table S3). AcrE is very similar to AcrA and
can substitute for AcrA function in multidrug transport, while
AcrR can repress acrAB operon expression (Hirakawa et al.,
2008; Hayashi et al., 2016). The acrS gene is upstream of acrE,
and the protein binds to the same sequence on the AcrA
promoter that is recognized by AcrR, thus potentially acting as
an AcrA repressor negatively regulating kanamycin resistance
(Hirakawa et al., 2008). As expected, the TolC protein was
identified in the membrane sub-proteome, expressed at low
levels (Supplementary Table S4). Outer membrane channel
TolC is involved in various eﬄux and drug transportation
systems like the tripartite systems EmrAB–TolC and MdtABC-
TolC/MdtEF-TolC, and other resistance eﬄux systems that
confer the capability to resist and expel a wide range of
antibiotics, detergents and chemical solvents (Tanabe et al., 2009;
Lennen et al., 2013; Anes et al., 2015). Genes emrA, emrB,
emrD, emrE, emrK, and emrR were identified in our RNA-
Seq survey at low expression levels (Supplementary Table 3,
below 124 FPKMs), while genes mdtA, mdtB, mdtC, mdtD,
mdtE, mdtG, mdtI, mdtJ, mdtK, mdtL, mdtM, mdtN, mdtO,
and mdtP showed slightly higher expression levels (above 274
FPKMs). Except for TolC, the above eﬄux system components
were not detected in the proteome. The lipid A-Ara4N
pathway is involved in polymyxin resistance because Ara4N (4-
amino-4-deoxy-L-arabinose) is added to phosphate groups of
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FIGURE 1 | Whole-cell proteome of E. coli C999. One-dimensional SDS-PAGE gel profile stained with Coomassie R-250 (left) with schematic profile showing
molecular weights. Two-dimensional gel stained with Coomassie G-250 with spots marked (right). Protein spot color key: dark red, stress response; orange, SOS
response; dark green, antibiotic resistance.
lipid A. Genes encoding lipid A-Ara4N pathway components
are well represented among the RNA-Seq data with arnC,
arnE, arnF, and arnT expressed between 64 and 45 FPKMs
(Supplementary Tables S3, S4; Gatzeva-Topalova et al., 2005b).
Even though the expression levels of the latter transcripts were
similar, only bifunctional polymyxin resistance protein ArnA
was expressing at low level in the membrane sub-proteome.
Polymyxin resistance is also triggered by the up-regulation of
operon arnBCADTEF, which is directly involved in the activation
of the two-component system PmrA/PmrB that is represented
in the RNA-Seq readout (Olaitan et al., 2014). Genes pmrA,
pmrB, pmrD, pmrG, pmrJ, pmrL, and pmrM were expressed at
under 178 FPKMs whilst the respective peptides they encode
were not detected. The presence of these resistance mechanisms
in clinical isolates with increased virulence raises concern
for the spontaneous polymyxin resistance phenomena thus
indicating why such bacteria reveal high pathogenic potential.
Some other abundant transcripts did not have corresponding
proteins in the proteomic data, which may be due to a number
of factors like post-translational mechanisms of regulation
and differential protein stability that can be influenced by a
protein’s location and/or interaction with other proteins, or
even due to limitations within the proteomic techniques (Yoon
et al., 2003; Hack, 2004; Kumar et al., 2016). In fact, the
correlation between transcript and protein levels may vary
according to specific patterns (Yoon et al., 2003). Immobilized
pH gradient 2DE is widely used for protein separation and
identification but have shown some limitations in resolving
highly charged, long chain and insoluble proteins (Hack, 2004).
Such proteins may therefore remain undetected with 2DE
and MS techniques or displaying levels of expression below
the define threshold, even when the corresponding genes
and transcripts are identified through WGS and RNA-Seq,
respectively. This reinforces the need to compare proteomic
and transcriptomic results in order to fully characterize a given
bacterial strain.
Proteins Related to Bacterial Resistance
Mechanisms
Antibiotic Resistance
Following several reports of the identification and expression
of antibiotic resistance genes around the world (Lavigne et al.,
2007; Mitsou et al., 2010; Barguigua et al., 2011; Kim et al.,
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FIGURE 2 | Two-dimensional gel of E. coli C999 of extracellular (A), periplasmic (B), membrane (C), and cytoplasmic (D) proteome fractions stained with
Coomassie G-250 with spots marked (right). Protein spot color key: dark red, stress response; orange, SOS response; dark green, antibiotic resistance.
2011), the dynamics of the proteome and the mechanism(s)
of bacterial antibiotic resistance need to be considered in the
context of the spread of bacterial pathogens (Cash, 2011).
Elongation factor Tu, encoded by tufA, was identified in
spot 46 [molecular weight (MW) 41636, isoelectric point (pI)
5.00] of the cytoplasm fraction (Figure 2). Present in most
enterobacterial genomes, TufA is responsible for binding and
transporting an appropriate codon-specified aminoacyl-tRNA to
the ribosome aminoacyl site, and it also influences the assembly
and stability of cytoskeletal polymers and is implicated in
protein folding and protection from stress (Caldas et al., 1998;
Isabel et al., 2008). Levels of TufA protein and transcripts were
found to be elevated in C999 which is relevant and consistent
with previous reports of tufA upregulated expression in the
presence of antibacterial peptide polymyxin B, regulated by the
pmrA/pmrB two-component system (Supplementary Table S2;
Isabel et al., 2008; Ribeiro et al., 2013). Another one of the
most expressed genes is β-lactamase TEM-1, which was present
in the periplasmic sub-proteome [MW 31666, pI 5.60] (see
Figure 6 and Supplementary Tables S3, S9). Plasmid-encoded
β-lactamases are among the most critical acquired resistance
determinants emerging in members of Enterobacteriaceae such
as E. coli (Hooff et al., 2012). The detection of this protein is
noteworthy, even though the level of expression was low and
poorly correlated with the mRNA levels determined by RNA-
Seq. It is also relevant to note that not any other β-lactamase
protein was found expressing, unlike the corresponding gene
blaCTX−M−15 frequently found carried in ST131 E. coli clones
accompanied by quinolone resistance gene aac(6’)-Ib-cr (Chong
et al., 2018). Similar uncorrelated levels of RNA and protein
expression were found for outer membrane protein TolC [spot
351], a component of the eﬄux pump system which rids the
cell of antibiotics like tetracycline (to which E. coli C999 is
resistant) and chloramphenicol (Weatherspoon-Griffin et al.,
2014). The antibiotic resistance related FabI protein, an enoyl-
[acyl-carrier-protein] reductase [NADH], was detected in spot
129 [MW 28074, pI 5.58] of the whole-cell proteome and in
spots 88, 89, and 146 of the cytoplasmic sub-proteome. The
detection of FabI in various spots, although it occurs at low
levels of protein expression, suggests the existence of post-
translational modification affecting protein stability (Maier et al.,
2009). FabI is a homo-tetrameric enzyme responsible for the
catalysis of the last reductive step of fatty acid biosynthesis,
and it is a critical target for antibacterials commonly used
mediating resistance to E. coli enterohemorrhagic serotypes
(see Supplementary Table S1). In Staphylococcus aureus, FabI
is known to be inhibited by triclosan, a broad-spectrum
antibacterial additive and hexachlorophene, which results in
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FIGURE 3 | Distribution of E. coli strain C999 proteins according to their predicted function in biological processes.
FabI being less effective toward Gram-negative bacteria (Heath
et al., 2000; Schiebel et al., 2014). The previously cited
bifunctional polymyxin resistance protein ArnA [spot 275] is a
pathway-specific enzyme possessing a C-terminal domain which
catalyzes the NAD+-dependent oxidative decarboxylation of
UDP-GlcA to UDP-β-(L-threopentapyranosyl-4′′-ulose) (UDP-
4-keto-pentose) (Gatzeva-Topalova et al., 2005b). This pathway
is implicated in the pathophysiological effects associated with
Gram-negative bacterial infections (Gatzeva-Topalova et al.,
2005a). Aminoglycoside 3′-phosphotransferase AphA [spot 73]
is reported to be involved in resistance to kanamycin and
structurally-related aminoglycosides like tobramycin (Shi et al.,
2013). Knowing that kanamycin and tobramycin were tested
when phenotyping C999, the detection of the AphA protein
confirms that the corresponding resistance is expressed at the
proteome level. It is interesting that while ArnA transcript levels
were consistently low, the AphA transcripts were not detected,
which suggests that some regulatory mechanisms remain to be
discovered. In the periplasmic fraction was detected the presence
of two hits of Ferrous iron transport protein A, a known virulent
factor, but under a very low protein score so that its identification
is not validated (Supplementary Table S9).
Stress Response, Oxidoreductase, and SOS
Response
The environmental stress response is a defense mechanism found
in all bacteria in which many different factors regulate gene and
protein expression according to the specific stress encountered
(Calabrese et al., 2012). The analysis of both the transcriptome
and proteomes of C999 revealed the presence of several genes
related to stress response mechanisms that increase the survival
rate of bacteria, a relevant factor when considering non-
commensal bacteria that will therefore endure. Stress response
associated Dps (DNA protection during starvation) protein
[spots 1, 6, and 157; MW 18684 and pI 5.70], another factor
contributing to the bacteria’s survival, was highly expressed in
both the whole-cell proteome and transcriptome (Figures 1, 2
and Supplementary Table S2). Very similar to ferritins, Dps
has a compact and stable shell-like structure assembled from
twelve identical subunits, with the lysine-rich N-termini of
each monomer conferring flexibility. When present in stationary
phase cells, Dps can bind DNA to form a highly stable DNA-
Dps complex, which protects bacteria from oxidative stress
or nutritional deprivation caused by harmful environmental
stimuli (Stephani et al., 2003; Calhoun and Kwon, 2011). The
highly stable protein conformation is also known to influence
E. coli attachment to abiotic surfaces (Goulter-Thorsen et al.,
2011). Expression of chaperone proteins ClpB [MW 95697,
pI 5.37], DnaK (HSP70) [MW 69130, pI 4.83], and 60 kDa
chaperonin GroEL1 [MW 57464, pI 4.85] is associated with the
stress response. DnaK (HSP70) is an ATP-dependent molecular
chaperone operating in thermal resistance in bacteria (Miot et al.,
2011). In conjunction with ClpB, the DnaK/HSP70 chaperone
system, is able to dissolve protein aggregates to protect bacterial
cells from the effects of protein inactivation and aggregation
caused by great heat stress (Doyle et al., 2007). ClpB is an
ATP-dependent molecular chaperone from the AAA+ ATPase
superfamily essential for bacterial thermotolerance that was
found in the C999 proteomes (see Supplementary Tables S5,
S6, S9; del Castillo et al., 2010; Miot et al., 2011). Another
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FIGURE 4 | Distribution of E. coli strain C999 proteins from cytoplasm and membrane fractions according to their predicted function in biological processes.
major E. coli chaperone, GroEL1, was found in whole-cell [spot
19] and also in the cytoplasm [spot 3], periplasm [spot 6] and
membrane fraction [spots 18, 19, and 20] (Richter et al., 2010).
GroEL belongs to the HSP60 class and plays an important
role in protein folding and heat stress resistance. In fact, all
three types of chaperones have similar biochemical structures
and are involved in protecting cells by resisting heat stress at
different stages of the bacterial chemical response (Kyratsous
and Panagiotidis, 2012). In terms of oxidative stress defense,
oxidoreductase function related proteins SodA [MW 23083, pI
6.44], AhpC [MW 20862, pI 5.03], and thiol peroxidase protein
(Tpx) [MW 17995, pI 4.75] were identified in the C999 whole-cell
proteome and AhpC was also identified in the C999 membrane
fraction (see Figure 1 and Supplementary Tables S5, S8).
Superoxide dismutase (SodA) removes superoxide leading to the
generation of hydrogen peroxide (H2O2) which is then removed
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FIGURE 5 | Distribution of E. coli strain C999 proteins from extracellular and periplasm fractions according to their predicted function in biological processes.
by catalases like KatE and peroxidases like AhpC, the latter being
a very extensively studied bacterial peroxiredoxin system (Jung
and Kim, 2003; Seib et al., 2006; Dubbs and Mongkolsuk, 2007).
Tpx is involved in the formation of biofilms alongside superoxide
dismutase (SodC) in Shiga toxin E. coli O157:H7 where these
periplasmic oxidative defense proteins are more highly expressed
under biofilm-inducing conditions (Kim et al., 2006). Peroxidases
Tpx and AhpC were also found to be expressed in Salmonella
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FIGURE 6 | Comparison of protein distribution among the different cellular fractions and whole-cell extract.
enterica where a tpx mutant is more susceptible to exogenous
H2O2 and is less able to degrade it than the wild type. Tpx
therefore contributes to the defense system of this pathogen
enabling it to survive oxidative stress (Horst et al., 2010).
Another bacterial stress response mechanism involves RNA
polymerase sigma factor RpoH, previously described as the
main regulator of the heat stress response. RpoH is induced
by protein unfolding and cytoplasmic stress in response to
heat, DNA damage or antibiotic exposure (see Supplementary
Table S8; Narberhaus and Balsiger, 2003; Foster, 2007). In our
survey, RpoH mRNA was expressed at a high level, but protein
expression was low, which might be expected as most heat
induced mechanisms are post-trancriptional (Narberhaus and
Balsiger, 2003). Also related to the general stress response is the
two-component system connector protein sensor-associating-
factor A (SafA), a 65-amino-acid membrane protein in whole
cells [spots 125 and 153] and in the periplasm [spot 13] that
is involved in the acid response network of two-component
signal transduction systems. In E. coli there are 14 gene products
and at least 15 regulators implicated in acid response (AR)
biochemistry, where GadE is the main activator protein of
resistance genes like gadA and gadE. Regulation of GadE in
turn involves several regulators like EvgA and PhoP (Masuda
and Church, 2003). EvgS/EvgA is the major system for acid
resistance in exponentially-proliferating cells, inducing SafA and
thus interacting and activating another connected regulating
system, the PhoQ/PhoP system (Eguchi et al., 2011). Also
relevant are the chaperone-related curved DNA-binding protein
and the Mdh oxidoreductase identified in whole-cell [spot 76],
cytoplasm [spot 73], and membrane [spot 305] fractions, and
ATP-dependent protease ATP-ase subunit HslU, characteristic of
E. coli O139:H28 (enterohemorrhagic strain E24377A), found
in the whole-cell [spot 164] and cytoplasm [spot 24] (Marzan
and Shimizu, 2011). SOS response components figured among
our results. The LexA repressor [spot 147; MW 22344, pI 9.64],
one of the main proteins regulating the SOS response, was
expressed at a low level even though its mRNA levels were high
(Figure 3 and Supplementary Tables S2, S5). LexA represses
the transcription of several genes involved in DNA damage
repair to a basal level when a bacterial cell is exposed to UV
or to widely used antibiotics, like β-lactams, fluoroquinolones
and trimethoprim (Guerin et al., 2011; Yaguchi et al., 2011).
Genes lexA-regulated have been shown to exhibit phenotypic
heterogeneity with different levels of expression detected in
different cell subpopulations. The heterogeneous expression is
related to differential binding affinity of LexA to SOS boxes when
DNA is damaged by external factors invoking the SOS response
(Kamensek et al., 2010). On the subject of DNA UV damage,
DNA replication and repair protein RecF [spot 169; MW 40717,
pI 6.78] was also found. The functional recF gene is implicated in
several forms of replication such as stable DNA replication and
linear plasmid multimer replication, as well as in the recovery of
replication in UV-irradiated E. coli cells. The RecF protein binds
preferentially to single-stranded or linear DNA that arises during
DNA metabolism such as replication and normal SOS induction,
and repairs DNA breaks and gaps resulting from UV or other
stresses. Cells lacking RecF pathway are thus hypersensitive to
UV-induced damage (Handa et al., 2009; Ona et al., 2009).
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CONCLUSION
In order to find a solution to the concern multidrug-resistance
in humans it is vital that researchers possess precise knowledge
of the gene and protein expression of the clinical bacterial
strains and whether they are related to pandemic strains such as
O25:H4-ST131, allowing to understand the dynamic framework
surrounding the expansion and endurance of such organisms.
In our study, we followed a previous genomic profile of clinical
strain E. coli C999 revealing characteristics of the extraintestinal
pathogenic CTX-M-15 producing E. coli clonal group O25:H4-
ST131 and exhibiting fluoroquinolone resistance as other
plasmid-mediated resistances. Through transcriptomics tools we
were able to confirm our strain to be O25:H4-ST131 and also
identify several genes related to antibiotic resistance and survival-
related processes like stress and SOS response. Proteomics
allowed the identification and quantification of several proteins
regarding also antibiotic resistance and stress response, within
some degree of correlation to the RNA expression. While
the proteomics data is very valuable, transcriptomics using
RNA-Seq provide precise transcript quantification so mRNA
and protein levels can be compared. However, the lack of
correlation between mRNA and protein expression (or the
difficulty in detecting it) indicates there is much to discover about
cellular mechanisms of gene regulation that could advance our
understanding of antibiotic resistance. It will be necessary to
investigate such relationships, particularly in terms of specific
stimuli, by increasing sampling frequency in a metaomics
approach, for example. In summary, omics-based studies of the
metabolic pathways of antibiotic resistance should continue to be
done if answers and sustainable solutions are to be found.
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